Zeus Pharmaceuticals Pvt Ltd
Founded in 1978 and headquartered in Gujarat, India.
1978 | Ahmedabad, Gujarat (India) | Active
Zeus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 46 Year, 4 Months
- Last Filing with ROC 31 Mar 2000
- Open Charges ₹ 1.20 M
About Zeus Pharmaceuticals
Zeus Pharmaceuticals Pvt Ltd (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 October 1978 and has a history of 46 years and four months. Its registered office is in Ahmedabad, Gujarat.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2000. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.20 M.
Company Details
- Location Ahmedabad, Gujarat
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1978PTC003223
- Company No.
003223
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 1978
- Date of AGM
30 Sep 2000
- Date of Balance Sheet
31 Mar 2000
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Chemicals
Pharmaceuticals
Who are the key members and board of directors at Zeus Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Zeus Pharmaceuticals.
Enhance accessibility to Zeus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zeus Pharmaceuticals?
Unlock access to Zeus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹1.20 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 1981 | Syndicate Bank | ₹1.00 M | Open |
| 22 Jun 1979 | Syndicate Bank | ₹0.20 M | Open |
How Many Employees Work at Zeus Pharmaceuticals?
Unlock and access historical data on people associated with Zeus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.